| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.09 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |